Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Renal Insufficiency » Acute Kidney Injury
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Renal Insufficiency » Acute Kidney Injury
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Kidney Diseases » Renal Insufficiency » Acute Kidney Injury
Description
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. MeSH
Hierarchy View
Subtype Terms (1)
Kidney Tubular Necrosis, Acute
8 drugs (5 approved, 3 experimental)
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (56)
Phase 3 Indicated Drugs (27)
Phase 2 Indicated Drugs (41)
Phase 1 Indicated Drugs (15)
Other Experimental Indicated Drugs (39)
Organization Involved with Phase 4 Indications (63)
Assistance Publique - Hôpitaux de Paris
Catholic University of Sacred Heart, Rome
Centro Universitario Ciencias de la Salud
Huazhong University of Science and Technology
Memorial University of Newfoundland
Misericordia and Dolce Hospital
Ospedale Misericordia e Dolce, Prato
People's Liberation Army of China
Southeast Renal Research Institute
Spanish Clinical Research Network
Taipei Veteran General hospital
Tokyo Medical and Dental University
University of California, Los Angeles
Organization Involved with Phase 3 Indications (84)
Bambino Gesù Hospital and Research Institute
Canadian Institutes of Health Research (CIHR)
Centre Hospitalier de Cherbourg
Centre Hospitalier de Tourcoing
Centre Hospitalier de Valenciennes
D'Annunzio University of Chieti–Pescara
Heart and Stroke Foundation of Canada
Hôpital Saint Philibert, Lomme
Instituto Nacional de Cardiologia Ignacio Chavez
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Medley Pharmaceutical Industry SA
National Autonomous University of Mexico
Rajaie Cardiovascular Medical and Research Center
Sapporo Higashi Tokushukai Hospital
Organization Involved with Phase 2 Indications (59)
Cohen Children's Medical Center of New York
Community Medical Center, Scranton, PA
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Federal University of Health Science of Porto Alegre
Hospital Universitario Ramon y Cajal
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Northern Health and Social Care Trust
Pulmonary and Critical Care Assoc. of Baltimore
Pulmonary Critical Care Associates of Baltimore
Russian Academy of Medical Sciences
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (27)
Alberta Heritage Foundation for Medical Research
Chinese Academy of Medical Sciences
Icahn School of Medicine at Mount Sinai
I.M. Sechenov First Moscow State Medical University
Institute of Liver and Biliary Sciences, India
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
